Novo Nordisk ® ted with sema reached ≥20% ved quality of life versus placebo Sema 2.4 mg showed a statistically significant treatment difference versus placebo in the IWQoL-Lite-CT PRO IQWoL-Lite-CT ETD [95% CI] Physical function 9.43 [7.50 : 11.35] * Physical 9.14 [7.31 : 10.96] * Psychological 10.50 [8.81 : 12.19] * Total 10.02 [8.42 : 11.62] * Favours placebo Favours semaglutide -2 0 2 4 6 8 10 12 14 16 18 20 statistically significant; p-values other than physical function were not controlled for multiplicity PRO: patient reported outcome; CI: confidence interval, ETD: estimated treatment difference, IWQoL-Lite-CT: Impact of Weight on Quality of Life-lite;
Download PDF file